The Tyler Medical Clinic

Assisted Conception - Affordable Infertility Treatments


Home FAQ Press Glossary Contact Us

About Tyler Medical Procedures Endometriosis Institute Westwood Cryobank IRMGT

- Cancer of the Ovary -

 

 

Risks of a son of a mother with genetic inclination to develop ovarian cancer

 

 

The genetic markers, commonly known as BRCA1 and/or BRCA2, are responsible for an increased risk of developing ovarian or breast cancer in females.

 

If a woman has a strong history of ovarian cancer and especially if she carries mutations in either BRCA1 or BRCA2 genes, she should do everything possible to have an unaffected and healthy child. The In Vitro Fertilization (IVF) combined with Preimplantation Genetic Diagnosis (PGD) can deliver just that, by identifying which embryos are females and which ones are males. By having a son, the mother will not transfer the risk of ovarian cancer to him and may be stopping the disease in future generations.

 

However, In Vitro Fertilization (IVF) combined with Preimplantation Genetic Diagnosis (PGD) cannot test for a complete genetic make-up of the embryo. For this reason, it cannot guarantee that the child will not develop other diseases. It will only guarantee that the son will not have ovarian cancer.

 

Click here for more information on PGD

 

Click here to learn about other diseases

 

Up


Home Up

The contents of The Tyler Medical Clinic Site, such as text, graphics, images, and other material ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on The Tyler Medical Clinic Site!

Copyright © 2001 The Tyler Medical Clinic
Last modified: 06/09/04